On Thursday, Humans of New York launched its 8th crowdfunding initiative through Indiegogo’s Generosity platform to raise $1 million for pediatric cancer research. The nonprofit organization teamed up with the Memorial Sloan Kettering Cancer Center for this new project.
Sharing details about the project, Humans of New York’s creator, Brandon Stanton, stated:
“Dr. Richard O’Reilly has been the Chairman of Pediatrics at Memorial Sloan Kettering Cancer Center for over thirty years. He’s a leading expert on bone marrow transplants and pioneered an approach that is now used to treat over 2,500 patients annually. In his position as chairman, he has helped lead a team of the world’s best doctors, nurses, and researchers in their battle to save lives. As one oncologist told me: ‘Dr. O’Reilly has never been able to distance himself from the outcome. He thinks we’ve failed if we don’t save every single kid.’ So let’s help him save every single kid. Dr. O’Reilly is stepping down this year, and in honor of his service, we are raising to aid in the fight against pediatric cancer.”
Stanton revealed that two-thirds of the campaign’s funds will go towards the research at Memorial Sloan Kettering. The remaining third will be used for psychologically and socially support to the young patients and families as they endure the long, tough battle against the illness. This will include non-medical services such as therapy and travel subsidies.
Stanton added:
“Funding is scarce for pediatric cancer. Because cancer most often occurs in older populations, pharmaceutical companies are not incentivized to develop treatments for cancers that develop during childhood. Therefore, nearly all funding for the research of pediatric cancer comes from private donations. Please consider donating, and let’s help empower Dr. O’Reilly and the team at Memorial Sloan Kettering as they work to end pediatric cancer. We’ve created donation levels that are appropriately themed for the battle.”
Since its launch, the campaign has successfully secured over $250,000 from 7500 supporters.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!
Sponsored Links by DQ Promote
Reg A - Form 1-A Filings Beta
Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.
YTD: Jan 1, 2026 - Oct 26, 2026 vs Jan 1, 2025 - Oct 26, 2025
Share this graph
Number of Filings131Prior 126 +4.0%
Target Raise, Total$3.40BPrior $3.54B -3.9%
This YTD
Year prior
Change
Filings
131
126
+4.0%
Target raise
$3.40B
$3.54B
-3.9%
Sponsored by
the Crowded Media Group
the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us@CrowdfundInside
This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.
Crowdfund Insider is the leading news website covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain, online lending, and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.
“Dr. Richard O’Reilly has been the Chairman of Pediatrics at Memorial Sloan Kettering Cancer Center for over thirty years. He’s a leading expert on bone marrow transplants and pioneered an approach that is now used to treat over 2,500 patients annually. In his position as chairman, he has helped lead a team of the world’s best doctors, nurses, and researchers in their battle to save lives. As one oncologist told me: ‘Dr. O’Reilly has never been able to distance himself from the outcome. He thinks we’ve failed if we don’t save every single kid.’ So let’s help him save every single kid. Dr. O’Reilly is stepping down this year, and in honor of his service, we are raising to aid in the fight against pediatric cancer.”
“Funding is scarce for pediatric cancer. Because cancer most often occurs in older populations, pharmaceutical companies are not incentivized to develop treatments for cancers that develop during childhood. Therefore, nearly all funding for the research of pediatric cancer comes from private donations. Please consider donating, and let’s help empower Dr. O’Reilly and the team at Memorial Sloan Kettering as they work to end pediatric cancer. We’ve created donation levels that are appropriately themed for the battle.”
